Following on from its Made in the USA campaign, New Balance is now personalising the fight against cancer. The company is celebrating the 20th anniversary of its partnership with the Susan G. Komen for the Cure charity by selling 20 limited edition 993 run shoes per day. The limited edition, personalised pink shoes form part of New Balance’s Lace up for the Cure campaign.
The campaign features stories of hope, inspiration and triumph – through New Balance’s 20 year partnership with the leading breast cancer charity. More than 100,000 volunteers and activists work through 125 Komen Affiliates to mobilise more than one million friends and neighbours every year through events such as the Komen Race for the Cure – the world’s largest and most successful awareness and fundraising event for breast cancer.
Celebrating over 100 years of making running shoes, New Balance is also focusing attention on its heritage of shoe production in the United States. A recently produced advert shows the importance of New Balance to local communities, as an employer and support to the economy.
New Balance claims that it is ‘the only athletic footwear manufacturer making shoes in the US.’ New Balance shoes are produced in Boston and Lawrence, in Massachusetts, and in Norridgewock, Norway and Skowhegan in Maine.
